Want to checkout our Free Trial?


Tepezza Lawsuits: Can You Make a Claim for Tepezza Hearing Loss?

by | Apr 8, 2024 | Product liability

Any sense that is compromised might seriously harm many components of your life. Your work, relationships, mental health, and overall quality of life can all be impacted by even a mild disability.

Tepezza is supposed to promote health, but when it worsens hearing problems, one may feel especially duped, given how much we rely on medications. Damages in Tepezza lawsuits may include the adverse impacts on a person’s life brought on by hearing problems due to Tepezza. Let’s take a look at long term Tepezza side effects and Tepezza lawsuits 2023.

Seeking quality reviews?

Get free trial to know our mettle

Hurry up!

creative cta - LezDo TechMed Blog

YouTube video

What is Tepezza? 

The body’s immune system attacks the muscles and tissue behind the eyes in Thyroid Eye Disease, which results in bulging eyes, discomfort, and impaired vision. Sometimes Graves’ illness results in TED.

In 2020, the FDA approved Tepezza (Teprotumumab), a relatively recent therapy for Thyroid Eye Disease. Since that time, more and more cases of Tepezza hearing adverse effects have been documented by physicians and patients.

How does tepezza work? For roughly five months, Tepezza is injected once every three weeks. Although the precise process by which Tepezza does this is not entirely known, Tepezza functions by stopping the immune system from attacking the fatty tissue behind the eyes. Tepezza was created by Horizon Therapeutics and is still covered under the first patent.

According to a news release from the FDA’s Center for Drug Evaluation and Research on January 21, 2020, the approval of Tepezza represented “significant advancements in the approval of efficient cures for uncommon disorders like thyroid eye disease.”

Furthermore, “Tepezza may change the course of the illness, sparing patients from having to undergo numerous invasive procedures.”

Unfortunately, Tepezza may carry a considerably higher risk of hearing issues than originally thought. We now understand that people receiving Tepezza as a TED treatment may be at risk for lifelong hearing problems, including unrecoverable hearing loss and tinnitus.

Tepezza Risk of Hearing Loss

In March 2021, The Endocrine Society released a small study that indicated 65% of Tepezza users might experience hearing issues due to the medication’s adverse effects.

The study’s authors specifically watched 26 individuals who received at least 4 Tepezza injections. Of these, 17 patients, or 65%, said they had trouble hearing. This proportion is exceedingly high and is six times more than the projected risk that Horizon indicated in the warning box.

Six or 23%, stated that they had Tepezza and hearing loss; seven, or 27%, experienced tinnitus or ear ringing; and three, or 12%, experienced ear plugging. Furthermore, 29% of test participants reported having autophony, in which their voices sounded abnormally loud to themselves.

According to the researchers, Tepezza’s hearing issues started after an average of 3.6 infusions. Four patients who complained of problems had sensorineural hearing loss, which happens when the inner ear’s hair cells are harmed.

In three patients, patulous eustachian tube disease was diagnosed, which causes the canal connecting the middle ear with the back of the nose and throat to remain open and results in a long-term hearing issue. The signs did not completely disappear but did become better with time.

The research authors recommended that new patients be evaluated before using Tepezza and that doctors be more aware of the possible hearing problems while giving the medication. The researchers also suggested that physicians do baseline audiogram examinations.

Tepezza Study: Long Term Side Effects of Tepezza

Numerous Tepezza lawsuits of injection-related permanent hearing loss have been documented since the product’s release. In a post-marketing study undertaken by Horizon on thousands of patients, it was discovered that 10% had hearing loss, the majority of which was mild to moderate and treatable. However, the research did not make a distinction.

Tepezza medication was only given “orphan status” by the FDA, which required further testing before Tepezza’s efficacy could be conclusively demonstrated. This is standard for drugs that treat uncommon illnesses for which there are currently no other appropriate therapy options.

For each particular drug, manufacturers must ask the FDA for orphan status. But even when an orphan medicine receives first approval, research is still done to demonstrate its efficacy and safety.

Numerous studies have connected Tepezza to severe hearing issues, including:

  • Hearing loss
  • Tinnitus
  • Plugged ears
  • Autophony

Only 10% of people who got Tepezza had hearing issues, according to the drug’s producer, Horizon Therapeutics, in pre-and post-market clinical trials. This is far less than what many other recent studies indicate.

The company also claimed that the hearing-related adverse effects in their clinical trials were generally “temporary,” even though other research has shown that Tepezza’s damaging effects can last long after stopping the drug.

People who got Tepezza injections for TED and later had hearing loss or tinnitus may be qualified to file a product liability claim and obtain financial compensation.

Does the Tepezza Label Include a Warning for Hearing Loss?

Temporary hearing loss in patients undergoing drug trials was included in Section 6 of the original Tepezza warning label. The Horizon appears to have misled the FDA about the reversibility of hearing loss.

The possibility that Tepezza side effects of hearing loss may be permanent is not included in the labeling or FDA clearance package.

One of the first hearing damage claims was made by an Arizona man diagnosed with permanent hearing loss. Tepezza lawsuits were filed against the makers of the controversial TED drug Tepezza that Horizon Therapeutics failed to warn patients and doctors about the possibility that Tepezza could harm hearing and cause tinnitus.

The Tepezza medicine label downplays the seriousness of the hearing issues purportedly connected to Tepezza, even though “many patient reports, scientific studies, and even the defendant’s post-marketing investigations have proved that Tepezza causes hearing loss,” according to the Tepezza lawsuits.

Tepezza Lawsuits for Hearing Loss

After getting Tepezza injections, patients with hearing loss or tinnitus started suing Horizon for product liability in 2022. According to the Tepezza hearing loss lawsuit, Horizon was negligent in adequately informing consumers and medical professionals about the real dangers of hearing impairment connected with Tepezza.

According to the plaintiffs in these Tepezza, neither they nor their doctors were aware of the possible risks associated with the medication since there was not a sufficient warning regarding the possibility of hearing impairment from Tepezza.

These plaintiffs contend that if Horizon had given adequate and appropriate notice about this danger, they would not have needed to take Tepezza to treat their TED.

As more and more Tepezza patients experience hearing loss, it is anticipated that hundreds of Tepezza lawsuits for hearing loss will be brought in the future. The Tepezza lawsuits have yet to be aggregated into a class action MDL, although that may happen in the future if many more similar complaints are filed.

Tepezza Lawsuit Update November 2023

Over the past month, only 5 new cases have been added to the Tepezza hearing loss class action MDL. As of November 16, 2023, there were 59 Tepezza cases pending in the MDL.

Tepezza Lawsuit Update 2024

April 2024

Horizon Therapeutics requested an extension to select Tepezza bellwether lawsuits due to extensive medical records involved, but plaintiffs opposed it, arguing that enough information was already available.

The court extended the deadline until May 30 but stated that no further extensions would be allowed. Plaintiffs’ request for raw clinical data was approved by the court, despite objections from the defendants, while their request for payment records was rejected for being overly broad and burdensome.

The MDL-3079 trialed in the court of Northern district of Illinois has 101 Tepezza lawsuits waiting to resolved, as per the latest update on April 1, 2024.

cta button - LezDo TechMed Blog

Discover hidden insights in medical records for a stronger case

By analyzing medical records, lawyers can see human mistakes, follow the development of therapies, examine the efficacy of pharmaceuticals, and make knowledgeable conclusions about a patient’s status. LezDo TechMed will review accurately using information from medical records.

To conclude,

It’s essential to take action in product liability cases as soon as you can because there is a statute of limitations for bringing legal action over harmful drugs. Let’s hope that the Tepezza lawsuits help the people recover their damages through settlements.

Visit our Instagram, to get more insights:


View this post on Instagram


A post shared by LezDo MedLegal (@lezdomedlegal)

Trending Posts

Get our trending newsletter delivered straight to your inbox.

This field is for validation purposes and should be left unchanged.

We are ready

to help you.

The only question is

will it be you?

error: Content is protected !!